E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 8.5 EUR -15.59% Market Closed
Market Cap: 1.5B EUR
Have any thoughts about
Evotec SE?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Evotec SE

Revenue
777.1m EUR
Cost of Revenue
-670.6m EUR
Gross Profit
106.5m EUR
Operating Expenses
-200.1m EUR
Operating Income
-93.6m EUR
Other Expenses
-77.8m EUR
Net Income
-171.4m EUR

Margins Comparison
Evotec SE Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Evotec SE
XETRA:EVT
1.5B EUR
14%
-12%
-22%
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
55%
14%
9%
US
Thermo Fisher Scientific Inc
NYSE:TMO
196.3B USD
41%
17%
14%
US
Danaher Corp
NYSE:DHR
170.3B USD
60%
21%
18%
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW
50%
31%
24%
CH
Lonza Group AG
SIX:LONN
37.6B CHF
29%
13%
9%
US
Agilent Technologies Inc
NYSE:A
38.5B USD
55%
25%
22%
US
IQVIA Holdings Inc
NYSE:IQV
36.7B USD
35%
14%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD
59%
28%
21%
US
West Pharmaceutical Services Inc
NYSE:WST
23B USD
35%
20%
17%
US
Illumina Inc
NASDAQ:ILMN
22.3B USD
64%
8%
-36%
Country DE
Market Cap 1.5B EUR
Gross Margin
14%
Operating Margin
-12%
Net Margin
-22%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 196.3B USD
Gross Margin
41%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 170.3B USD
Gross Margin
60%
Operating Margin
21%
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Gross Margin
50%
Operating Margin
31%
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Gross Margin
29%
Operating Margin
13%
Net Margin
9%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Operating Margin
25%
Net Margin
22%
Country US
Market Cap 36.7B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 26.4B USD
Gross Margin
59%
Operating Margin
28%
Net Margin
21%
Country US
Market Cap 23B USD
Gross Margin
35%
Operating Margin
20%
Net Margin
17%
Country US
Market Cap 22.3B USD
Gross Margin
64%
Operating Margin
8%
Net Margin
-36%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Evotec SE Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Evotec SE
XETRA:EVT
1.5B EUR
-16%
-8%
-5%
-5%
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
3%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
196.3B USD
13%
6%
9%
7%
US
Danaher Corp
NYSE:DHR
170.3B USD
8%
5%
6%
5%
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW
10%
6%
11%
7%
CH
Lonza Group AG
SIX:LONN
37.6B CHF
6%
3%
6%
5%
US
Agilent Technologies Inc
NYSE:A
38.5B USD
25%
13%
18%
17%
US
IQVIA Holdings Inc
NYSE:IQV
36.7B USD
22%
5%
11%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD
-611%
24%
49%
29%
US
West Pharmaceutical Services Inc
NYSE:WST
23B USD
18%
13%
18%
17%
US
Illumina Inc
NASDAQ:ILMN
22.3B USD
-37%
-18%
5%
5%
Country DE
Market Cap 1.5B EUR
ROE
-16%
ROA
-8%
ROCE
-5%
ROIC
-5%
Country US
Market Cap 1.3T USD
ROE
3%
ROA
2%
ROCE
3%
ROIC
3%
Country US
Market Cap 196.3B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
7%
Country US
Market Cap 170.3B USD
ROE
8%
ROA
5%
ROCE
6%
ROIC
5%
Country KR
Market Cap 66.5T KRW
ROE
10%
ROA
6%
ROCE
11%
ROIC
7%
Country CH
Market Cap 37.6B CHF
ROE
6%
ROA
3%
ROCE
6%
ROIC
5%
Country US
Market Cap 38.5B USD
ROE
25%
ROA
13%
ROCE
18%
ROIC
17%
Country US
Market Cap 36.7B USD
ROE
22%
ROA
5%
ROCE
11%
ROIC
9%
Country US
Market Cap 26.4B USD
ROE
-611%
ROA
24%
ROCE
49%
ROIC
29%
Country US
Market Cap 23B USD
ROE
18%
ROA
13%
ROCE
18%
ROIC
17%
Country US
Market Cap 22.3B USD
ROE
-37%
ROA
-18%
ROCE
5%
ROIC
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top